Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Depreciation & Amortization (CF) (2016 - 2025)

IGC Pharma has reported Depreciation & Amortization (CF) over the past 16 years, most recently at $119000.0 for Q3 2025.

  • Quarterly Depreciation & Amortization (CF) fell 17.93% to $119000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $571000.0 through Sep 2025, down 9.51% year-over-year, with the annual reading at $618000.0 for FY2025, 2.98% down from the prior year.
  • Depreciation & Amortization (CF) was $119000.0 for Q3 2025 at IGC Pharma, down from $141000.0 in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $172000.0 in Q4 2022 and troughed at $119000.0 in Q3 2025.
  • The 5-year median for Depreciation & Amortization (CF) is $160000.0 (2023), against an average of $157315.8.
  • Year-over-year, Depreciation & Amortization (CF) skyrocketed 121.33% in 2021 and then fell 17.93% in 2025.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $166000.0 in 2021, then increased by 3.61% to $172000.0 in 2022, then fell by 6.98% to $160000.0 in 2023, then dropped by 1.88% to $157000.0 in 2024, then fell by 24.2% to $119000.0 in 2025.
  • Per Business Quant, the three most recent readings for IGC's Depreciation & Amortization (CF) are $119000.0 (Q3 2025), $141000.0 (Q2 2025), and $154000.0 (Q1 2025).